Biotech & pharma · Newsletter guide
The best biotech and pharma newsletters, free and paid
Biopharma runs on FDA decisions, trial readouts, and dealmaking — and its professionals read newsletters obsessively. These are the trade dailies the industry actually opens. The most popular biotech and pharma newsletters in 2026.
We check each newsletter is still publishing, note whether it's free or paid, and link straight to the official signup. We don't take payment for placement.
BioPharma Dive
Journalist-written pharma and biotech news: FDA, deals, and clinical trials.
The reliable free daily backbone of the beat.
The Readout
STAT's daily on the business of biotech, written by name-brand journalists.
Sharp, skeptical, and first to the story more often than not.
Fierce Biotech
The long-running flagship daily on pharma and biotech industry news.
Two decades of trade coverage, still free.
Frequently asked
- What's the best free biotech and pharma newsletter?
- BioPharma Dive, The Readout and Fierce Biotech are the most popular free picks on this list; each links straight to its official signup above.
- How can I listen to my biotech and pharma newsletters instead of reading them?
- Add the ones you like to your Hark newsletters. We deliver them to your private Hark address and turn them into a five-minute spoken briefing each morning, your personal inbox is never involved.
- How did you choose these?
- We include newsletters that are currently publishing, note whether each is free or paid, and link to the official signup. We don't take payment for placement, and we don't reproduce newsletter content; we point you to the source.
Last updated: July 2026